Immunogenic cell death-associated biomarkers classification predicts prognosis and immunotherapy efficacy in pancreatic ductal adenocarcinoma

HIGHLIGHTS

• who: Wenguang Peng and colleagues from the Westmead Institute for Medical Research, Australia Hong Kong Baptist University, Hong Kong have published the research work: Immunogenic cell death-associated biomarkers classification predicts prognosis and immunotherapy efficacy in pancreatic ductal adenocarcinoma, in the Journal: (JOURNAL) of December/31,/2015
• what: This study examined the differences in the tumor microenvironment between two subtypes. The authors focused on the link between survival status and risk score. Although this model is effective in predicting the prognosis of PDAC, this study has a number of drawbacks.
• how: The authors . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.